Market by Procedure, Type of Infection, Industry Vertical, Product, and Country | Forecast 2021-2028
A
Triton Market Research report states that the surgical site infection control
market in the Asia-Pacific is expected to grow in revenue terms with 6.52% of
CAGR over the projected phase between 2021 and 2028.
Report scope can be customized per your requirements. Request For Customization
The
countries studied in this market include:
• China
• India
• Japan
• South Korea
• Australia & New Zealand
• ASEAN countries
• Rest of APAC countries
Surgical
site infections have been highly prevalent in China, and numerous studies have
been performed to quantify the rate of prevalence of these infections. SSIs are
a burden to the healthcare system as well as the patients, because of the
extended hospital stay and additional treatment required. Consequently, various
strategies have been formulated and interventions have been made to reduce the
incidence of SSIs. These efforts are expected to save costs and improve the
healthcare system efficiency, and, at the same time, benefit the market for
surgical site infection control in China.
SSI
surveillance is not just an exercise to investigate the cause for the incidence
of these infections, but also an activity to control infection and reduce
surgical site infection rates. An SSI surveillance program called ‘Japanese
Nosocomial Infection Surveillance’ was initiated in Japan in 1999, by the
Japanese Society of Environmental Infections. Furthermore, a nation-wide
surgical site infection surveillance program was started by the Japanese
Ministry of Health and Welfare in July 2002. This was followed by the
establishment of an SSI surveillance study group in October, the same year.
This group was founded to support the Ministry’s surgical site infection
surveillance program, increase the number of awareness activities and enhance
the quality of SSI surveillance in the country. These activities are helping
the Japanese SSI control market to flourish in the coming years.
Ansell
is engaged in designing, developing, and manufacturing an extensive range of
surgical, industrial, examination, & household gloves and protective
clothing, among others. The company has four major business segments: Medical, Industrial,
Single Use, and Sexual Wellness. ENCORE Latex Acclaim ENCORE, Latex Underglove,
ENCORE Radiation Attenuation, and GAMMEX PI Radiation Attenuation are some of
the products it manufactures for SSI control. The company is headquartered in
Victoria, Australia. In August 2020, Ansell entered into a partnership with
OneMed; a company providing medical supplies and support systems to distribute
its products throughout its existing distribution network.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. ASIA-PACIFIC
SURGICAL SITE INFECTION CONTROL MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
DEFINITION
2.2. PORTER’S
FIVE FORCES MODEL
2.2.1.
THREAT OF NEW ENTRANTS
2.2.2.
THREAT OF SUBSTITUTE PRODUCTS
2.2.3.
BARGAINING POWER OF BUYERS
2.2.4.
BARGAINING POWER OF SUPPLIERS
2.2.5.
COMPETITIVE RIVALRY
2.3. IMPACT
OF COVID-19 ON SURGICAL SITE INFECTION CONTROL MARKET
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VENDOR
SCORECARD
2.6. KEY
INSIGHTS
2.7. MARKET
DRIVERS
2.7.1.
ENACTMENT OF BEST INFECTION
PREVENTION AND CONTROL PRACTICES
2.7.2.
GROWING AGING POPULATION
2.8. MARKET
RESTRAINTS
2.8.1.
LACK OF INFECTION CONTROL
PROGRAMS
2.8.2.
SURGING USE OF OUTPATIENT
PROCEDURES
2.8.3.
INCREASED USAGE OF MEDICAL
DISPOSABLE ITEMS
2.9. MARKET
OPPORTUNITIES
2.9.1.
RISING INCIDENCE OF SURGICAL
PROCEDURES
2.9.2.
SIGNIFICANT RISE IN OCCURRENCE
OF COMPLICATIONS FROM HEALTHCARE-ASSOCIATED INFECTIONS
3. SURGICAL
SITE INFECTION CONTROL MARKET OUTLOOK – BY PROCEDURE
3.1. LAPAROSCOPY
3.2. ORTHOPEDIC
SURGERY
3.3. CARDIOVASCULAR
3.4. OBSTETRICS
AND GYNECOLOGY
3.5. WOUND
CLOSURE
3.6. PLASTIC
& RECONSTRUCTIVE SURGERY
3.7. THORACIC
SURGERY
3.8. MICROVASCULAR
3.9. UROLOGY
3.10. NEUROSURGERY
3.11. OTHER
PROCEDURES
4. SURGICAL
SITE INFECTION CONTROL MARKET OUTLOOK – BY TYPE OF INFECTION
4.1. SUPERFICIAL
INCISIONAL SSI
4.2. DEEP
INCISIONAL SSI
4.3. ORGAN
OR SPACE SSI
5. SURGICAL
SITE INFECTION CONTROL MARKET OUTLOOK – BY INDUSTRY VERTICAL
5.1. HOSPITALS
5.2. AMBULATORY
SURGICAL CENTERS
6. SURGICAL
SITE INFECTION CONTROL MARKET OUTLOOK – BY PRODUCT
6.1. DISINFECTANTS
6.2. MANUAL
REPROCESSORS SOLUTION
6.3. SURGICAL
DRAPES
6.4. SURGICAL
GLOVES
6.5. SKIN
PREPARATION SOLUTION
6.6. SURGICAL
IRRIGATION
6.7. SURGICAL
SCRUBS
6.8. HAIR
CLIPPERS
6.9. MEDICAL
NONWOVENS
6.10. OTHER
PRODUCTS
7. SURGICAL
SITE INFECTION CONTROL MARKET – ASIA-PACIFIC
7.1.
COUNTRY ANALYSIS
7.1.1. CHINA
7.1.2. JAPAN
7.1.3. INDIA
7.1.4. AUSTRALIA
& NEW ZEALAND
7.1.5. SOUTH
KOREA
7.1.6. ASEAN
COUNTRIES
7.1.7. REST
OF ASIA-PACIFIC
8. COMPANY
PROFILES
8.1. SOTERA
HEALTH LLC
8.2. PACON
MANUFACTURING CORPORATION
8.3. STERIS
CORPORATION
8.4. AMERICAN
POLYFILM
8.5. BIOMERIEUX
SA
8.6. STRYKER
CORPORATION
8.7. BELIMED
AG
8.8. GAMA
HEALTHCARE
8.9. BECTON
DICKINSON AND COMPANY (BD)
8.10. 3M
COMPANY
8.11. GETINGE
AB
8.12. JOHNSON
& JOHNSON
8.13. ANSELL
LTD
8.14. KIMBERLY-CLARK
8.15. LAC-MAC
9. RESEARCH
METHODOLOGY & SCOPE
9.1. RESEARCH
SCOPE & DELIVERABLES
9.1.1.
OBJECTIVES OF STUDY
9.1.2.
SCOPE OF STUDY
9.2. SOURCES
OF DATA
9.2.1.
PRIMARY DATA SOURCES
9.2.2.
SECONDARY DATA SOURCES
9.3. RESEARCH
METHODOLOGY
9.3.1.
EVALUATION OF PROPOSED MARKET
9.3.2.
IDENTIFICATION OF DATA SOURCES
9.3.3.
ASSESSMENT OF MARKET
DETERMINANTS
9.3.4.
DATA COLLECTION
9.3.5.
DATA VALIDATION & ANALYSIS
TABLE
1 ASIA-PACIFIC SURGICAL SITE
INFECTION CONTROL MARKET 2021-2028 (IN $ MILLION)
TABLE
2 VENDOR SCORECARD
TABLE
3 ASIA-PACIFIC SURGICAL SITE
INFECTION CONTROL, BY PROCEDURE, 2021-2028 (IN $ MILLION)
TABLE
4 ASIA-PACIFIC SURGICAL SITE
INFECTION CONTROL, BY TYPE OF INFECTION, 2021-2028 (IN $ MILLION)
TABLE
5 ASIA-PACIFIC SURGICAL SITE
INFECTION CONTROL, BY INDUSTRY VERTICAL, 2021-2028 (IN $ MILLION)
TABLE
5 ASIA-PACIFIC SURGICAL SITE
INFECTION CONTROL, BY PRODUCT, 2021-2028 (IN $ MILLION)
TABLE
6 ASIA-PACIFIC SURGICAL SITE
INFECTION CONTROL MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
FIGURE
1 ASIA-PACIFIC SURGICAL SITE
INFECTION CONTROL MARKET 2021-2028 (IN $ MILLION)
FIGURE
2 TYPES OF HEALTHCARE-ASSOCIATED
INFECTIONS
FIGURE
3 ASIA-PACIFIC SURGICAL SITE
INFECTION CONTROL MARKET, BY LAPAROSCOPY, 2021-2028 (IN $ MILLION)
FIGURE
4 ASIA-PACIFIC SURGICAL SITE
INFECTION CONTROL MARKET, BY ORTHOPEDIC SURGERY, 2021-2028 (IN $ MILLION)
FIGURE
5 ASIA-PACIFIC SURGICAL SITE
INFECTION CONTROL MARKET, BY CARDIOVASCULAR, 2021-2028 (IN $ MILLION)
FIGURE
6 ASIA-PACIFIC SURGICAL SITE
INFECTION CONTROL MARKET, BY OBSTETRICS AND GYNECOLOGY, 2021-2028 (IN $
MILLION)
FIGURE
7 ASIA-PACIFIC SURGICAL SITE
INFECTION CONTROL MARKET, BY WOUND CLOSURE, 2021-2028 (IN $ MILLION)
FIGURE
8 ASIA-PACIFIC SURGICAL SITE
INFECTION CONTROL MARKET, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2021-2028
(IN $ MILLION)
FIGURE
9 ASIA-PACIFIC SURGICAL SITE
INFECTION CONTROL MARKET, BY THORACIC SURGERY, 2021-2028 (IN $ MILLION)
FIGURE
10 ASIA-PACIFIC SURGICAL SITE INFECTION
CONTROL MARKET, BY MICROVASCULAR, 2021-2028 (IN $ MILLION)
FIGURE
11 ASIA-PACIFIC SURGICAL SITE INFECTION
CONTROL MARKET, BY UROLOGY, 2021-2028 (IN $ MILLION)
FIGURE
12 ASIA-PACIFIC SURGICAL SITE INFECTION
CONTROL MARKET, BY NEUROSURGERY, 2021-2028 (IN $ MILLION)
FIGURE
13 ASIA-PACIFIC SURGICAL SITE INFECTION
CONTROL MARKET, BY OTHER PROCEDURES, 2021-2028 (IN $ MILLION)
FIGURE
14 ASIA-PACIFIC SURGICAL SITE INFECTION
CONTROL MARKET, BY SUPERFICIAL INCISIONAL SSI, 2021-2028 (IN $ MILLION)
FIGURE
15 ASIA-PACIFIC SURGICAL SITE INFECTION
CONTROL MARKET, BY DEEP INCISIONAL SSI, 2021-2028 (IN $ MILLION)
FIGURE
16 ASIA-PACIFIC SURGICAL SITE INFECTION
CONTROL MARKET, BY ORGAN OR SPACE SSI, 2021-2028 (IN $ MILLION)
FIGURE
17 ASIA-PACIFIC SURGICAL SITE INFECTION
CONTROL MARKET, BY HOSPITALS, 2021-2028 (IN $ MILLION)
FIGURE
18 ASIA-PACIFIC SURGICAL SITE INFECTION
CONTROL MARKET, BY AMBULATORY SURGICAL CENTERS, 2021-2028 (IN $ MILLION)
FIGURE
19 ASIA-PACIFIC SURGICAL SITE INFECTION
CONTROL MARKET, BY DISINFECTANTS, 2021-2028 (IN $ MILLION)
FIGURE
20 ASIA-PACIFIC SURGICAL SITE INFECTION
CONTROL MARKET, BY MANUAL REPROCESSORS SOLUTION, 2021-2028 (IN $ MILLION)
FIGURE
21 ASIA-PACIFIC SURGICAL SITE INFECTION
CONTROL MARKET, BY SURGICAL DRAPES, 2021-2028 (IN $ MILLION)
FIGURE
22 ASIA-PACIFIC SURGICAL SITE INFECTION
CONTROL MARKET, BY SURGICAL GLOVES, 2021-2028 (IN $ MILLION)
FIGURE
23 ASIA-PACIFIC SURGICAL SITE INFECTION
CONTROL MARKET, BY SKIN PREPARATION SOLUTION, 2021-2028 (IN $ MILLION)
FIGURE
24 ASIA-PACIFIC SURGICAL SITE INFECTION
CONTROL MARKET, BY SURGICAL IRRIGATION, 2021-2028 (IN $ MILLION)
FIGURE
25 ASIA-PACIFIC SURGICAL SITE INFECTION
CONTROL MARKET, BY SURGICAL SCRUBS, 2021-2028 (IN $ MILLION)
FIGURE
26 ASIA-PACIFIC SURGICAL SITE INFECTION
CONTROL MARKET, BY HAIR CLIPPERS, 2021-2028 (IN $ MILLION)
FIGURE
27 ASIA-PACIFIC SURGICAL SITE INFECTION
CONTROL MARKET, BY MEDICAL NONWOVENS, 2021-2028 (IN $ MILLION)
FIGURE
28 ASIA-PACIFIC SURGICAL SITE INFECTION
CONTROL MARKET, BY OTHER PRODUCTS, 2021-2028 (IN $ MILLION)
FIGURE
29 CHINA SURGICAL SITE INFECTION CONTROL
MARKET 2021-2028 (IN $ MILLION)
FIGURE
30 JAPAN SURGICAL SITE INFECTION CONTROL
MARKET 2021-2028 (IN $ MILLION)
FIGURE
31 INDIA SURGICAL SITE INFECTION CONTROL
MARKET 2021-2028 (IN $ MILLION)
FIGURE
32 AUSTRALIA & NEW ZEALAND SURGICAL
SITE INFECTION CONTROL MARKET 2021-2028 (IN $ MILLION)
FIGURE
33 SOUTH KOREA SURGICAL SITE INFECTION
CONTROL MARKET 2021-2028 (IN $ MILLION)
FIGURE
34 ASEAN COUNTRIES SURGICAL SITE
INFECTION CONTROL MARKET 2021-2028 (IN $ MILLION)
FIGURE
35 REST OF ASIA-PACIFIC SURGICAL SITE
INFECTION CONTROL MARKET 2021-2028 (IN $ MILLION)